

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 7.47433757 |
| 2 | synaptic vesicle maturation (GO:0016188) | 7.40506675 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 7.28910229 |
| 4 | axon ensheathment (GO:0008366) | 7.25538345 |
| 5 | ensheathment of neurons (GO:0007272) | 7.25538345 |
| 6 | myelination (GO:0042552) | 7.21225195 |
| 7 | glutamate secretion (GO:0014047) | 6.90858511 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 6.28114565 |
| 9 | cellular potassium ion homeostasis (GO:0030007) | 6.00400278 |
| 10 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.88568920 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.87178368 |
| 12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.75857416 |
| 13 | sodium ion export (GO:0071436) | 5.58605977 |
| 14 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.36739409 |
| 15 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.32869082 |
| 16 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.18361136 |
| 17 | myelin maintenance (GO:0043217) | 5.08410395 |
| 18 | neurotransmitter secretion (GO:0007269) | 5.02524326 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 5.00959965 |
| 20 | oligodendrocyte differentiation (GO:0048709) | 4.94333897 |
| 21 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.91461017 |
| 22 | locomotory exploration behavior (GO:0035641) | 4.69752515 |
| 23 | potassium ion homeostasis (GO:0055075) | 4.58364754 |
| 24 | negative regulation of neurotransmitter transport (GO:0051589) | 4.57421075 |
| 25 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 4.54918689 |
| 26 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.47556955 |
| 27 | potassium ion import (GO:0010107) | 4.46392204 |
| 28 | cholesterol biosynthetic process (GO:0006695) | 4.41225457 |
| 29 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.38267842 |
| 30 | glycerophospholipid catabolic process (GO:0046475) | 4.36122989 |
| 31 | creatine metabolic process (GO:0006600) | 4.29017152 |
| 32 | positive regulation of synapse maturation (GO:0090129) | 4.27859388 |
| 33 | postsynaptic membrane organization (GO:0001941) | 4.26579130 |
| 34 | L-amino acid import (GO:0043092) | 4.24760998 |
| 35 | regulation of collateral sprouting (GO:0048670) | 4.24576655 |
| 36 | vocalization behavior (GO:0071625) | 4.23694056 |
| 37 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.22200027 |
| 38 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.20676593 |
| 39 | neurotransmitter transport (GO:0006836) | 4.15309262 |
| 40 | presynaptic membrane organization (GO:0097090) | 4.14004762 |
| 41 | astrocyte development (GO:0014002) | 4.13353245 |
| 42 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.09734783 |
| 43 | negative regulation of protein localization to cell surface (GO:2000009) | 4.06291516 |
| 44 | establishment of mitochondrion localization (GO:0051654) | 4.05349330 |
| 45 | photoreceptor cell differentiation (GO:0046530) | 4.03318917 |
| 46 | eye photoreceptor cell differentiation (GO:0001754) | 4.03318917 |
| 47 | presynaptic membrane assembly (GO:0097105) | 3.93562418 |
| 48 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.92853140 |
| 49 | peripheral nervous system axon ensheathment (GO:0032292) | 3.91888517 |
| 50 | myelination in peripheral nervous system (GO:0022011) | 3.91888517 |
| 51 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.90475065 |
| 52 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.89714997 |
| 53 | exploration behavior (GO:0035640) | 3.85750166 |
| 54 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.85088434 |
| 55 | sterol biosynthetic process (GO:0016126) | 3.84231001 |
| 56 | asymmetric protein localization (GO:0008105) | 3.81052429 |
| 57 | apical protein localization (GO:0045176) | 3.80329990 |
| 58 | regulation of synaptic plasticity (GO:0048167) | 3.80020490 |
| 59 | adhesion of symbiont to host cell (GO:0044650) | 3.76774481 |
| 60 | virion attachment to host cell (GO:0019062) | 3.76774481 |
| 61 | response to methylmercury (GO:0051597) | 3.76228609 |
| 62 | regulation of neurotransmitter levels (GO:0001505) | 3.75981227 |
| 63 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.75724957 |
| 64 | neuromuscular process controlling balance (GO:0050885) | 3.73359017 |
| 65 | acidic amino acid transport (GO:0015800) | 3.71245641 |
| 66 | amyloid precursor protein metabolic process (GO:0042982) | 3.68430483 |
| 67 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.68085746 |
| 68 | transmission of nerve impulse (GO:0019226) | 3.66462624 |
| 69 | * substantia nigra development (GO:0021762) | 3.66013646 |
| 70 | response to redox state (GO:0051775) | 3.65880139 |
| 71 | regulation of neurotransmitter secretion (GO:0046928) | 3.62073510 |
| 72 | positive regulation of membrane potential (GO:0045838) | 3.61925841 |
| 73 | synaptic transmission, glutamatergic (GO:0035249) | 3.61730012 |
| 74 | adult walking behavior (GO:0007628) | 3.57810229 |
| 75 | import into cell (GO:0098657) | 3.57146535 |
| 76 | positive regulation of dendritic spine development (GO:0060999) | 3.57100436 |
| 77 | cellular sodium ion homeostasis (GO:0006883) | 3.54689476 |
| 78 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.53893468 |
| 79 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.53104735 |
| 80 | regulation of ARF protein signal transduction (GO:0032012) | 3.50723620 |
| 81 | long-term synaptic potentiation (GO:0060291) | 3.50352215 |
| 82 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.49421239 |
| 83 | cell communication by electrical coupling (GO:0010644) | 3.48605261 |
| 84 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.47119286 |
| 85 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.44845629 |
| 86 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.44718718 |
| 87 | neuronal ion channel clustering (GO:0045161) | 3.40750491 |
| 88 | regulation of neurotransmitter transport (GO:0051588) | 3.40202248 |
| 89 | isoprenoid biosynthetic process (GO:0008299) | 3.39202825 |
| 90 | glutamate receptor signaling pathway (GO:0007215) | 3.33727772 |
| 91 | regulation of synapse maturation (GO:0090128) | 3.33557484 |
| 92 | synaptic vesicle endocytosis (GO:0048488) | 3.33476536 |
| 93 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.32485985 |
| 94 | membrane tubulation (GO:0097320) | 3.31322433 |
| 95 | L-glutamate transport (GO:0015813) | 3.30666199 |
| 96 | neuronal action potential propagation (GO:0019227) | 3.30567278 |
| 97 | protein localization to synapse (GO:0035418) | 3.29960290 |
| 98 | regulation of synapse structural plasticity (GO:0051823) | 3.29785199 |
| 99 | gamma-aminobutyric acid transport (GO:0015812) | 3.28712280 |
| 100 | negative regulation of inclusion body assembly (GO:0090084) | 3.27077729 |
| 101 | long-term memory (GO:0007616) | 3.26734886 |
| 102 | positive regulation of action potential (GO:0045760) | 3.26679194 |
| 103 | neuron-neuron synaptic transmission (GO:0007270) | 3.25919503 |
| 104 | response to lipoprotein particle (GO:0055094) | 3.24318131 |
| 105 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.23473968 |
| 106 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.23031403 |
| 107 | regulation of postsynaptic membrane potential (GO:0060078) | 3.21641234 |
| 108 | cellular response to epinephrine stimulus (GO:0071872) | 3.20305161 |
| 109 | protein palmitoylation (GO:0018345) | 3.18770229 |
| 110 | magnesium ion transport (GO:0015693) | 3.16940432 |
| 111 | regulation of dendritic spine development (GO:0060998) | 3.16895980 |
| 112 | amino acid import (GO:0043090) | 3.13793247 |
| 113 | neuron cell-cell adhesion (GO:0007158) | 3.12587029 |
| 114 | regulation of vesicle fusion (GO:0031338) | 3.12151472 |
| 115 | regulation of synaptic transmission (GO:0050804) | 3.11424225 |
| 116 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.10686089 |
| 117 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.10354349 |
| 118 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.09540009 |
| 119 | peripheral nervous system development (GO:0007422) | 3.07214802 |
| 120 | negative regulation of JUN kinase activity (GO:0043508) | 3.06340801 |
| 121 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.03971266 |
| 122 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.03857570 |
| 123 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.02624577 |
| 124 | positive regulation of neurotransmitter transport (GO:0051590) | 3.02499186 |
| 125 | glycosylceramide metabolic process (GO:0006677) | 3.02268836 |
| 126 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.01018773 |
| 127 | negative regulation of axon extension (GO:0030517) | 3.00544301 |
| 128 | cerebellar Purkinje cell layer development (GO:0021680) | 2.98424026 |
| 129 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.98164057 |
| 130 | astrocyte differentiation (GO:0048708) | 2.97785690 |
| 131 | neuromuscular process controlling posture (GO:0050884) | 2.96484160 |
| 132 | auditory behavior (GO:0031223) | 2.95748751 |
| 133 | * negative regulation of axonogenesis (GO:0050771) | 2.95559715 |
| 134 | detection of calcium ion (GO:0005513) | 2.91715573 |
| 135 | layer formation in cerebral cortex (GO:0021819) | 2.89869454 |
| 136 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.89809833 |
| 137 | limb bud formation (GO:0060174) | 2.88280703 |
| 138 | cerebellar granule cell differentiation (GO:0021707) | 2.88081514 |
| 139 | neuron remodeling (GO:0016322) | 2.86632004 |
| 140 | response to epinephrine (GO:0071871) | 2.84674871 |
| 141 | glycine transport (GO:0015816) | 2.81129624 |
| 142 | axon development (GO:0061564) | 2.80337288 |
| 143 | glial cell development (GO:0021782) | 2.78399481 |
| 144 | very long-chain fatty acid metabolic process (GO:0000038) | 2.78344248 |
| 145 | GPI anchor biosynthetic process (GO:0006506) | 2.72818345 |
| 146 | adhesion of symbiont to host (GO:0044406) | 2.72403879 |
| 147 | cellular response to monoamine stimulus (GO:0071868) | 2.71618063 |
| 148 | cellular response to catecholamine stimulus (GO:0071870) | 2.71618063 |
| 149 | peptidyl-cysteine modification (GO:0018198) | 2.71151758 |
| 150 | neurotransmitter catabolic process (GO:0042135) | 2.69874579 |
| 151 | GPI anchor metabolic process (GO:0006505) | 2.68093282 |
| 152 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.63793190 |
| 153 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.63018927 |
| 154 | nerve growth factor signaling pathway (GO:0038180) | 2.62400410 |
| 155 | cyclic nucleotide catabolic process (GO:0009214) | 2.60703052 |
| 156 | amyloid precursor protein catabolic process (GO:0042987) | 2.59466208 |
| 157 | nucleotide transmembrane transport (GO:1901679) | 2.56746954 |
| 158 | membrane assembly (GO:0071709) | 2.56195260 |
| 159 | glial cell differentiation (GO:0010001) | 2.56167382 |
| 160 | dendritic spine morphogenesis (GO:0060997) | 2.56121808 |
| 161 | thioester biosynthetic process (GO:0035384) | 2.55344189 |
| 162 | acyl-CoA biosynthetic process (GO:0071616) | 2.55344189 |
| 163 | response to hepatocyte growth factor (GO:0035728) | 2.55127074 |
| 164 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.55127074 |
| 165 | enteric nervous system development (GO:0048484) | 2.54957746 |
| 166 | positive regulation of glial cell differentiation (GO:0045687) | 2.52527564 |
| 167 | response to monoamine (GO:0071867) | 2.50277043 |
| 168 | response to catecholamine (GO:0071869) | 2.50277043 |
| 169 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.49710140 |
| 170 | organ growth (GO:0035265) | 2.49619552 |
| 171 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.49130750 |
| 172 | neurotransmitter uptake (GO:0001504) | 2.47862353 |
| 173 | positive regulation of gliogenesis (GO:0014015) | 2.47146471 |
| 174 | regulation of dopamine metabolic process (GO:0042053) | 2.45430427 |
| 175 | regulation of catecholamine metabolic process (GO:0042069) | 2.45430427 |
| 176 | axon ensheathment in central nervous system (GO:0032291) | 11.2613532 |
| 177 | central nervous system myelination (GO:0022010) | 11.2613532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.27940042 |
| 2 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.02936074 |
| 3 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.61256237 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.52517812 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.51082663 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.50102848 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.44760647 |
| 8 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.42792793 |
| 9 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.20434688 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.20183471 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.20183471 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.19140480 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.16421197 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.10337233 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.08676854 |
| 16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.05989018 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.04791019 |
| 18 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.04507560 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.03538184 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.01001094 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.97451989 |
| 22 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.97411733 |
| 23 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.95227202 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.95174207 |
| 25 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.90025279 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89909478 |
| 27 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.85671662 |
| 28 | KDM2B_26808549_Chip-Seq_K562_Human | 1.83874803 |
| 29 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.82033397 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.81188868 |
| 31 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.80677057 |
| 32 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.74282941 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.74078421 |
| 34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.73691219 |
| 35 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.68130655 |
| 36 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.67433153 |
| 37 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.67415681 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.64377840 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.60236529 |
| 40 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.59661412 |
| 41 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.55041943 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.53463460 |
| 43 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.52125552 |
| 44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.48058105 |
| 45 | VDR_22108803_ChIP-Seq_LS180_Human | 1.47779708 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.47454327 |
| 47 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.47276080 |
| 48 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.46183973 |
| 49 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.45462744 |
| 50 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.44147472 |
| 51 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.36857367 |
| 52 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.35631742 |
| 53 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.34148075 |
| 54 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33384587 |
| 55 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.33096137 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.33068361 |
| 57 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.32947620 |
| 58 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.30816790 |
| 59 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.30718971 |
| 60 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.30664620 |
| 61 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.30307240 |
| 62 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.29858661 |
| 63 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26775440 |
| 64 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26206730 |
| 65 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25737350 |
| 66 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.24425224 |
| 67 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23457463 |
| 68 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.22292255 |
| 69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22039293 |
| 70 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.19549007 |
| 71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.19518136 |
| 72 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.17486975 |
| 73 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.16872378 |
| 74 | P300_19829295_ChIP-Seq_ESCs_Human | 1.15374530 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15032159 |
| 76 | STAT3_23295773_ChIP-Seq_U87_Human | 1.14515697 |
| 77 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.14430680 |
| 78 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13922634 |
| 79 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.11758300 |
| 80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11529956 |
| 81 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09461086 |
| 82 | AR_19668381_ChIP-Seq_PC3_Human | 1.09114859 |
| 83 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08133135 |
| 84 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.07328468 |
| 85 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.07290069 |
| 86 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.06230253 |
| 87 | FUS_26573619_Chip-Seq_HEK293_Human | 1.06089933 |
| 88 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04717496 |
| 89 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04717496 |
| 90 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.02818208 |
| 91 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02316843 |
| 92 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02310743 |
| 93 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00459016 |
| 94 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00227012 |
| 95 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00039567 |
| 96 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99854740 |
| 97 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98148897 |
| 98 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.98115482 |
| 99 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.98005695 |
| 100 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97518907 |
| 101 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97107251 |
| 102 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96563744 |
| 103 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96437147 |
| 104 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.95690028 |
| 105 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.95514268 |
| 106 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95104695 |
| 107 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94731205 |
| 108 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.94706122 |
| 109 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.94562786 |
| 110 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.94173593 |
| 111 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93725549 |
| 112 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91814154 |
| 113 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.91809597 |
| 114 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.91603786 |
| 115 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.91261256 |
| 116 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91146579 |
| 117 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91020323 |
| 118 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.90565188 |
| 119 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90015480 |
| 120 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89514692 |
| 121 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89467468 |
| 122 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89157623 |
| 123 | TBL1_22424771_ChIP-Seq_293T_Human | 0.87815968 |
| 124 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.87612504 |
| 125 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.86898574 |
| 126 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.85970183 |
| 127 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85900226 |
| 128 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85540413 |
| 129 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.85157992 |
| 130 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84952385 |
| 131 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84828385 |
| 132 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.84742089 |
| 133 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.84456739 |
| 134 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84181122 |
| 135 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.83617151 |
| 136 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.83612321 |
| 137 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.83167185 |
| 138 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.80161173 |
| 139 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.79524590 |
| 140 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.78853222 |
| 141 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.78601378 |
| 142 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.78238160 |
| 143 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.77894638 |
| 144 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77574250 |
| 145 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.76607131 |
| 146 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.76114819 |
| 147 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.75942761 |
| 148 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.74976029 |
| 149 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.72683206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0000920_abnormal_myelination | 5.23836099 |
| 2 | MP0003880_abnormal_central_pattern | 4.42431157 |
| 3 | MP0004270_analgesia | 3.61489477 |
| 4 | MP0003690_abnormal_glial_cell | 3.32955639 |
| 5 | MP0003950_abnormal_plasma_membrane | 3.03142675 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 2.99964164 |
| 7 | MP0004885_abnormal_endolymph | 2.86230501 |
| 8 | MP0003329_amyloid_beta_deposits | 2.77694370 |
| 9 | MP0002272_abnormal_nervous_system | 2.76043131 |
| 10 | MP0001529_abnormal_vocalization | 2.72791150 |
| 11 | MP0001486_abnormal_startle_reflex | 2.71674069 |
| 12 | MP0005171_absent_coat_pigmentation | 2.65738455 |
| 13 | MP0004742_abnormal_vestibular_system | 2.60698336 |
| 14 | MP0002064_seizures | 2.54617715 |
| 15 | MP0001905_abnormal_dopamine_level | 2.40882614 |
| 16 | MP0004142_abnormal_muscle_tone | 2.39737457 |
| 17 | * MP0003634_abnormal_glial_cell | 2.27381103 |
| 18 | MP0000778_abnormal_nervous_system | 2.20764637 |
| 19 | MP0001485_abnormal_pinna_reflex | 2.20176189 |
| 20 | MP0009046_muscle_twitch | 2.18840469 |
| 21 | MP0003136_yellow_coat_color | 2.17817726 |
| 22 | MP0003635_abnormal_synaptic_transmissio | 2.14377471 |
| 23 | MP0009745_abnormal_behavioral_response | 2.11406065 |
| 24 | MP0005409_darkened_coat_color | 2.02768300 |
| 25 | MP0005423_abnormal_somatic_nervous | 2.00970178 |
| 26 | MP0002734_abnormal_mechanical_nocicepti | 1.93513647 |
| 27 | MP0003879_abnormal_hair_cell | 1.93199790 |
| 28 | MP0003632_abnormal_nervous_system | 1.92175752 |
| 29 | * MP0002229_neurodegeneration | 1.81152407 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.73871976 |
| 31 | MP0005410_abnormal_fertilization | 1.71167956 |
| 32 | MP0005451_abnormal_body_composition | 1.67957052 |
| 33 | MP0000955_abnormal_spinal_cord | 1.62368024 |
| 34 | MP0010678_abnormal_skin_adnexa | 1.61682549 |
| 35 | MP0000462_abnormal_digestive_system | 1.60099322 |
| 36 | MP0003787_abnormal_imprinting | 1.57683591 |
| 37 | MP0000383_abnormal_hair_follicle | 1.55913721 |
| 38 | MP0002572_abnormal_emotion/affect_behav | 1.55149981 |
| 39 | MP0002063_abnormal_learning/memory/cond | 1.53619424 |
| 40 | MP0001440_abnormal_grooming_behavior | 1.51675049 |
| 41 | MP0004381_abnormal_hair_follicle | 1.51242175 |
| 42 | MP0008569_lethality_at_weaning | 1.50387932 |
| 43 | MP0002882_abnormal_neuron_morphology | 1.48242190 |
| 44 | MP0003631_nervous_system_phenotype | 1.46970369 |
| 45 | MP0001984_abnormal_olfaction | 1.45662613 |
| 46 | MP0000604_amyloidosis | 1.43574700 |
| 47 | MP0005551_abnormal_eye_electrophysiolog | 1.37886198 |
| 48 | MP0004147_increased_porphyrin_level | 1.36261763 |
| 49 | MP0002067_abnormal_sensory_capabilities | 1.35557060 |
| 50 | * MP0002066_abnormal_motor_capabilities/c | 1.34663505 |
| 51 | MP0005386_behavior/neurological_phenoty | 1.33071618 |
| 52 | MP0004924_abnormal_behavior | 1.33071618 |
| 53 | MP0004043_abnormal_pH_regulation | 1.32317332 |
| 54 | MP0001970_abnormal_pain_threshold | 1.31808655 |
| 55 | MP0002822_catalepsy | 1.27032896 |
| 56 | MP0003633_abnormal_nervous_system | 1.26011385 |
| 57 | MP0005167_abnormal_blood-brain_barrier | 1.24591151 |
| 58 | MP0000747_muscle_weakness | 1.24300363 |
| 59 | MP0003123_paternal_imprinting | 1.23197437 |
| 60 | MP0001963_abnormal_hearing_physiology | 1.22595644 |
| 61 | MP0003075_altered_response_to | 1.21466711 |
| 62 | MP0002733_abnormal_thermal_nociception | 1.20450484 |
| 63 | MP0001299_abnormal_eye_distance/ | 1.18498610 |
| 64 | MP0004134_abnormal_chest_morphology | 1.17751498 |
| 65 | MP0002752_abnormal_somatic_nervous | 1.16627901 |
| 66 | MP0005623_abnormal_meninges_morphology | 1.14762604 |
| 67 | MP0001346_abnormal_lacrimal_gland | 1.10922601 |
| 68 | MP0008260_abnormal_autophagy | 1.09163067 |
| 69 | MP0001968_abnormal_touch/_nociception | 1.05188335 |
| 70 | MP0006276_abnormal_autonomic_nervous | 1.00574821 |
| 71 | MP0003195_calcinosis | 0.96167512 |
| 72 | MP0000566_synostosis | 0.92825899 |
| 73 | MP0001177_atelectasis | 0.92549450 |
| 74 | MP0005058_abnormal_lysosome_morphology | 0.92025132 |
| 75 | MP0003122_maternal_imprinting | 0.91193351 |
| 76 | MP0001501_abnormal_sleep_pattern | 0.90256449 |
| 77 | MP0002152_abnormal_brain_morphology | 0.89619081 |
| 78 | MP0004145_abnormal_muscle_electrophysio | 0.88751894 |
| 79 | MP0003938_abnormal_ear_development | 0.88108296 |
| 80 | MP0001661_extended_life_span | 0.87352881 |
| 81 | MP0005195_abnormal_posterior_eye | 0.85642315 |
| 82 | MP0000647_abnormal_sebaceous_gland | 0.82527816 |
| 83 | MP0002735_abnormal_chemical_nociception | 0.81578174 |
| 84 | MP0001851_eye_inflammation | 0.81451430 |
| 85 | MP0004811_abnormal_neuron_physiology | 0.80466509 |
| 86 | MP0002184_abnormal_innervation | 0.78887380 |
| 87 | MP0000026_abnormal_inner_ear | 0.77566526 |
| 88 | MP0002736_abnormal_nociception_after | 0.76990055 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 0.76497390 |
| 90 | MP0002295_abnormal_pulmonary_circulatio | 0.74986560 |
| 91 | MP0002557_abnormal_social/conspecific_i | 0.74359600 |
| 92 | MP0005408_hypopigmentation | 0.74281136 |
| 93 | MP0001986_abnormal_taste_sensitivity | 0.73994604 |
| 94 | MP0001348_abnormal_lacrimal_gland | 0.71643480 |
| 95 | MP0005253_abnormal_eye_physiology | 0.70384149 |
| 96 | MP0000762_abnormal_tongue_morphology | 0.70209453 |
| 97 | MP0005535_abnormal_body_temperature | 0.69724460 |
| 98 | MP0001502_abnormal_circadian_rhythm | 0.69583765 |
| 99 | MP0006082_CNS_inflammation | 0.66657895 |
| 100 | MP0006072_abnormal_retinal_apoptosis | 0.66630084 |
| 101 | MP0003937_abnormal_limbs/digits/tail_de | 0.65681228 |
| 102 | MP0000579_abnormal_nail_morphology | 0.65361822 |
| 103 | MP0000467_abnormal_esophagus_morphology | 0.65096884 |
| 104 | MP0002090_abnormal_vision | 0.64820335 |
| 105 | MP0003137_abnormal_impulse_conducting | 0.64609244 |
| 106 | MP0002069_abnormal_eating/drinking_beha | 0.63361656 |
| 107 | MP0001727_abnormal_embryo_implantation | 0.59999503 |
| 108 | MP0003172_abnormal_lysosome_physiology | 0.58913488 |
| 109 | MP0002638_abnormal_pupillary_reflex | 0.57857866 |
| 110 | MP0002909_abnormal_adrenal_gland | 0.55838859 |
| 111 | MP0005646_abnormal_pituitary_gland | 0.55819109 |
| 112 | MP0010769_abnormal_survival | 0.54494151 |
| 113 | MP0005166_decreased_susceptibility_to | 0.53766381 |
| 114 | MP0000639_abnormal_adrenal_gland | 0.52691381 |
| 115 | MP0008874_decreased_physiological_sensi | 0.52498148 |
| 116 | MP0004133_heterotaxia | 0.52280673 |
| 117 | MP0008438_abnormal_cutaneous_collagen | 0.52204688 |
| 118 | MP0002133_abnormal_respiratory_system | 0.51811326 |
| 119 | MP0010768_mortality/aging | 0.50924428 |
| 120 | MP0010770_preweaning_lethality | 0.50230360 |
| 121 | MP0002082_postnatal_lethality | 0.50230360 |
| 122 | MP0002089_abnormal_postnatal_growth/wei | 0.49637767 |
| 123 | MP0001943_abnormal_respiration | 0.49459410 |
| 124 | MP0003045_fibrosis | 0.49012258 |
| 125 | MP0004130_abnormal_muscle_cell | 0.48962252 |
| 126 | MP0005388_respiratory_system_phenotype | 0.46954550 |
| 127 | MP0003956_abnormal_body_size | 0.45976224 |
| 128 | MP0008872_abnormal_physiological_respon | 0.44146999 |
| 129 | MP0002873_normal_phenotype | 0.43429163 |
| 130 | MP0001731_abnormal_postnatal_growth | 0.42646034 |
| 131 | MP0008877_abnormal_DNA_methylation | 0.41683261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.45855948 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.45855948 |
| 3 | Neurofibrillary tangles (HP:0002185) | 6.01386155 |
| 4 | Sensory axonal neuropathy (HP:0003390) | 5.36007175 |
| 5 | Peripheral hypomyelination (HP:0007182) | 4.99400504 |
| 6 | Parakeratosis (HP:0001036) | 4.98548682 |
| 7 | Focal seizures (HP:0007359) | 4.96192875 |
| 8 | Abnormality of the corticospinal tract (HP:0002492) | 4.89281740 |
| 9 | Diplopia (HP:0000651) | 4.76381233 |
| 10 | Abnormality of binocular vision (HP:0011514) | 4.76381233 |
| 11 | Cerebral hypomyelination (HP:0006808) | 4.73382905 |
| 12 | Febrile seizures (HP:0002373) | 4.34076273 |
| 13 | Cerebral inclusion bodies (HP:0100314) | 4.28070197 |
| 14 | Onion bulb formation (HP:0003383) | 4.11790993 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 4.06309535 |
| 16 | Spastic gait (HP:0002064) | 3.92552433 |
| 17 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.81860899 |
| 18 | Alacrima (HP:0000522) | 3.59445932 |
| 19 | Intention tremor (HP:0002080) | 3.57990994 |
| 20 | Abnormal auditory evoked potentials (HP:0006958) | 3.49682391 |
| 21 | Termporal pattern (HP:0011008) | 3.48691108 |
| 22 | Insidious onset (HP:0003587) | 3.48691108 |
| 23 | Myokymia (HP:0002411) | 3.48657270 |
| 24 | Dysmetria (HP:0001310) | 3.47019412 |
| 25 | Abnormal eating behavior (HP:0100738) | 3.44303333 |
| 26 | Visual hallucinations (HP:0002367) | 3.40741780 |
| 27 | Generalized tonic-clonic seizures (HP:0002069) | 3.32881132 |
| 28 | Postural instability (HP:0002172) | 3.31506234 |
| 29 | Slow saccadic eye movements (HP:0000514) | 3.28079145 |
| 30 | Akinesia (HP:0002304) | 3.20234037 |
| 31 | Obstructive sleep apnea (HP:0002870) | 3.14801775 |
| 32 | Limb dystonia (HP:0002451) | 3.13583917 |
| 33 | Ankle clonus (HP:0011448) | 3.11251557 |
| 34 | Spastic paraparesis (HP:0002313) | 3.09354905 |
| 35 | Torticollis (HP:0000473) | 3.07466477 |
| 36 | Mutism (HP:0002300) | 3.00913393 |
| 37 | Leukodystrophy (HP:0002415) | 2.97917457 |
| 38 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.96978791 |
| 39 | Progressive cerebellar ataxia (HP:0002073) | 2.96300907 |
| 40 | Scanning speech (HP:0002168) | 2.93657118 |
| 41 | Tetraplegia (HP:0002445) | 2.91793604 |
| 42 | Hemiplegia (HP:0002301) | 2.88222614 |
| 43 | Annular pancreas (HP:0001734) | 2.86943832 |
| 44 | Decreased lacrimation (HP:0000633) | 2.85993483 |
| 45 | CNS hypomyelination (HP:0003429) | 2.85929237 |
| 46 | Neuronal loss in central nervous system (HP:0002529) | 2.84787840 |
| 47 | Truncal ataxia (HP:0002078) | 2.82760141 |
| 48 | Papilledema (HP:0001085) | 2.81182141 |
| 49 | Absence seizures (HP:0002121) | 2.81171777 |
| 50 | Retinal dysplasia (HP:0007973) | 2.75401602 |
| 51 | Abnormality of the periventricular white matter (HP:0002518) | 2.75014465 |
| 52 | Delusions (HP:0000746) | 2.74507187 |
| 53 | Insomnia (HP:0100785) | 2.72820303 |
| 54 | Dialeptic seizures (HP:0011146) | 2.70665016 |
| 55 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.67417517 |
| 56 | Rigidity (HP:0002063) | 2.67033537 |
| 57 | Increased serum pyruvate (HP:0003542) | 2.65368963 |
| 58 | Abnormality of glycolysis (HP:0004366) | 2.65368963 |
| 59 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.65357333 |
| 60 | Depression (HP:0000716) | 2.62878293 |
| 61 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.56511556 |
| 62 | Thickened helices (HP:0000391) | 2.54597069 |
| 63 | Hypoplastic pelvis (HP:0008839) | 2.54390108 |
| 64 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.53645601 |
| 65 | Focal dystonia (HP:0004373) | 2.53085905 |
| 66 | Dysdiadochokinesis (HP:0002075) | 2.52567420 |
| 67 | Premature skin wrinkling (HP:0100678) | 2.51820202 |
| 68 | Increased circulating renin level (HP:0000848) | 2.50520071 |
| 69 | Apathy (HP:0000741) | 2.49647780 |
| 70 | Anteriorly placed anus (HP:0001545) | 2.49108783 |
| 71 | Bradykinesia (HP:0002067) | 2.48024257 |
| 72 | Morphological abnormality of the inner ear (HP:0011390) | 2.47442898 |
| 73 | Anxiety (HP:0000739) | 2.47396289 |
| 74 | Sleep apnea (HP:0010535) | 2.45540353 |
| 75 | Absent septum pellucidum (HP:0001331) | 2.42438141 |
| 76 | Rapidly progressive (HP:0003678) | 2.40236302 |
| 77 | Action tremor (HP:0002345) | 2.39117413 |
| 78 | Craniofacial dystonia (HP:0012179) | 2.38996746 |
| 79 | Split foot (HP:0001839) | 2.34444721 |
| 80 | Hemiparesis (HP:0001269) | 2.33874007 |
| 81 | Clumsiness (HP:0002312) | 2.31615854 |
| 82 | Status epilepticus (HP:0002133) | 2.31182061 |
| 83 | Pheochromocytoma (HP:0002666) | 2.30666543 |
| 84 | Cerebral hemorrhage (HP:0001342) | 2.29494844 |
| 85 | Paraparesis (HP:0002385) | 2.25722937 |
| 86 | Lower limb muscle weakness (HP:0007340) | 2.25646148 |
| 87 | Stridor (HP:0010307) | 2.25115588 |
| 88 | Diminished motivation (HP:0000745) | 2.23500442 |
| 89 | Poor speech (HP:0002465) | 2.20064858 |
| 90 | Autoamputation (HP:0001218) | 2.18079659 |
| 91 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.17996184 |
| 92 | Aplasia of the phalanges of the hand (HP:0009802) | 2.17996184 |
| 93 | Aplasia involving bones of the extremities (HP:0009825) | 2.17996184 |
| 94 | Megalencephaly (HP:0001355) | 2.17445168 |
| 95 | Poor eye contact (HP:0000817) | 2.17362945 |
| 96 | Coronal craniosynostosis (HP:0004440) | 2.16826695 |
| 97 | White forelock (HP:0002211) | 2.16523253 |
| 98 | Atonic seizures (HP:0010819) | 2.16198152 |
| 99 | Spastic tetraparesis (HP:0001285) | 2.15585956 |
| 100 | Epileptiform EEG discharges (HP:0011182) | 2.13716917 |
| 101 | Patchy hypopigmentation of hair (HP:0011365) | 2.09493342 |
| 102 | Hypomagnesemia (HP:0002917) | 2.08617535 |
| 103 | Foot dorsiflexor weakness (HP:0009027) | 2.07432938 |
| 104 | Focal motor seizures (HP:0011153) | 2.07408135 |
| 105 | Bundle branch block (HP:0011710) | 2.06940743 |
| 106 | Memory impairment (HP:0002354) | 2.06705226 |
| 107 | Abnormality of the lower motor neuron (HP:0002366) | 2.06441410 |
| 108 | Clonus (HP:0002169) | 2.05710159 |
| 109 | Hypoplasia of the iris (HP:0007676) | 2.04556659 |
| 110 | Metabolic alkalosis (HP:0200114) | 2.03300160 |
| 111 | Abnormality of the septum pellucidum (HP:0007375) | 2.02915860 |
| 112 | Decreased motor nerve conduction velocity (HP:0003431) | 2.02574014 |
| 113 | Spastic paraplegia (HP:0001258) | 2.00013879 |
| 114 | Neuroendocrine neoplasm (HP:0100634) | 1.99441970 |
| 115 | Partial agenesis of the corpus callosum (HP:0001338) | 1.98714732 |
| 116 | Urinary incontinence (HP:0000020) | 1.97186110 |
| 117 | Bowel incontinence (HP:0002607) | 1.97140694 |
| 118 | Impaired smooth pursuit (HP:0007772) | 1.95898875 |
| 119 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.93991504 |
| 120 | Paraplegia (HP:0010550) | 1.93513826 |
| 121 | Distal sensory impairment (HP:0002936) | 1.93058050 |
| 122 | Infantile muscular hypotonia (HP:0008947) | 1.92723263 |
| 123 | Hepatosplenomegaly (HP:0001433) | 1.92356066 |
| 124 | Cupped ear (HP:0000378) | 1.92325814 |
| 125 | Methylmalonic acidemia (HP:0002912) | 1.91978559 |
| 126 | Urinary urgency (HP:0000012) | 1.91638434 |
| 127 | Hammertoe (HP:0001765) | 1.91115061 |
| 128 | Humeroradial synostosis (HP:0003041) | 1.90103041 |
| 129 | Synostosis involving the elbow (HP:0003938) | 1.90103041 |
| 130 | Slow progression (HP:0003677) | 1.89900251 |
| 131 | Axonal loss (HP:0003447) | 1.87958212 |
| 132 | Turricephaly (HP:0000262) | 1.87679178 |
| 133 | Abnormality of the foot musculature (HP:0001436) | 1.86278746 |
| 134 | Impaired vibratory sensation (HP:0002495) | 1.85538739 |
| 135 | EEG with generalized epileptiform discharges (HP:0011198) | 1.84660034 |
| 136 | Esophageal atresia (HP:0002032) | 1.84341872 |
| 137 | Abnormal large intestine physiology (HP:0012700) | 1.84271459 |
| 138 | Choreoathetosis (HP:0001266) | 1.84120296 |
| 139 | Generalized myoclonic seizures (HP:0002123) | 1.84099038 |
| 140 | Steppage gait (HP:0003376) | 1.83831328 |
| 141 | Epileptic encephalopathy (HP:0200134) | 1.81929699 |
| 142 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.81910220 |
| 143 | Hypokalemic alkalosis (HP:0001949) | 1.81359131 |
| 144 | Erythroderma (HP:0001019) | 1.78595905 |
| 145 | Diminished movement (HP:0002374) | 1.77397010 |
| 146 | Partial duplication of thumb phalanx (HP:0009944) | 1.76683587 |
| 147 | Abnormality of saccadic eye movements (HP:0000570) | 1.74228403 |
| 148 | Peripheral demyelination (HP:0011096) | 1.73050869 |
| 149 | Muscle fiber splitting (HP:0003555) | 1.68664666 |
| 150 | Gowers sign (HP:0003391) | 1.68609234 |
| 151 | Renal Fanconi syndrome (HP:0001994) | 1.66892239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.10472626 |
| 2 | OXSR1 | 4.53333451 |
| 3 | DAPK2 | 3.28823949 |
| 4 | EPHB1 | 3.28573725 |
| 5 | TNIK | 2.87782808 |
| 6 | CDK19 | 2.87256980 |
| 7 | BCR | 2.68317448 |
| 8 | PKN1 | 2.58123166 |
| 9 | WNK4 | 2.47619874 |
| 10 | PRPF4B | 2.25931398 |
| 11 | CAMKK1 | 2.15661603 |
| 12 | MET | 2.10535467 |
| 13 | FGFR2 | 2.09422166 |
| 14 | WNK1 | 2.07484864 |
| 15 | LIMK1 | 2.07024506 |
| 16 | PBK | 2.05315589 |
| 17 | UHMK1 | 2.03089242 |
| 18 | NEK6 | 2.02159253 |
| 19 | MAPKAPK5 | 1.89762078 |
| 20 | ICK | 1.87968645 |
| 21 | EPHA4 | 1.80059736 |
| 22 | CSNK1G3 | 1.79609311 |
| 23 | CSNK1A1L | 1.72659370 |
| 24 | RIPK1 | 1.71886023 |
| 25 | NTRK1 | 1.65174158 |
| 26 | PAK6 | 1.60371630 |
| 27 | RIPK4 | 1.57536659 |
| 28 | ROCK2 | 1.55186314 |
| 29 | PLK2 | 1.54755687 |
| 30 | CAMK2B | 1.53178732 |
| 31 | PNCK | 1.51458523 |
| 32 | GRK5 | 1.40202904 |
| 33 | CSNK1G2 | 1.40148760 |
| 34 | CLK1 | 1.37316411 |
| 35 | CSNK1G1 | 1.36834114 |
| 36 | CAMK2D | 1.28098292 |
| 37 | TESK2 | 1.27684800 |
| 38 | ALK | 1.25899642 |
| 39 | LATS2 | 1.25177032 |
| 40 | FGR | 1.22294829 |
| 41 | TYRO3 | 1.21531782 |
| 42 | CAMK1 | 1.19893322 |
| 43 | SGK223 | 1.17684760 |
| 44 | SGK494 | 1.17684760 |
| 45 | CASK | 1.15549327 |
| 46 | MARK1 | 1.10894648 |
| 47 | DAPK1 | 1.05571468 |
| 48 | CAMK2G | 1.01685222 |
| 49 | MST4 | 0.99197235 |
| 50 | CDK14 | 0.96151176 |
| 51 | CDK5 | 0.94996451 |
| 52 | MAPK12 | 0.94770352 |
| 53 | ARAF | 0.93405098 |
| 54 | SGK2 | 0.92995379 |
| 55 | MARK2 | 0.88496861 |
| 56 | PAK3 | 0.88496840 |
| 57 | CDK15 | 0.86324438 |
| 58 | SGK3 | 0.85090985 |
| 59 | SIK2 | 0.84190470 |
| 60 | PRKCQ | 0.82996686 |
| 61 | STK38 | 0.82742427 |
| 62 | CDK18 | 0.81058158 |
| 63 | BMPR2 | 0.79160358 |
| 64 | CAMK2A | 0.79144793 |
| 65 | SGK1 | 0.78984638 |
| 66 | CDK11A | 0.77629976 |
| 67 | DYRK2 | 0.76458303 |
| 68 | MAP3K13 | 0.73946721 |
| 69 | CAMKK2 | 0.73428690 |
| 70 | BRSK1 | 0.73190441 |
| 71 | PDPK1 | 0.72850473 |
| 72 | KSR2 | 0.72139972 |
| 73 | MUSK | 0.71805670 |
| 74 | IRAK2 | 0.71563841 |
| 75 | PRKD1 | 0.70925576 |
| 76 | PHKG1 | 0.69447897 |
| 77 | PHKG2 | 0.69447897 |
| 78 | MAP3K11 | 0.66995208 |
| 79 | MAPK15 | 0.64923155 |
| 80 | TNK2 | 0.64569236 |
| 81 | RPS6KA3 | 0.62613678 |
| 82 | NTRK2 | 0.61453750 |
| 83 | PRKCE | 0.59140637 |
| 84 | MAP3K9 | 0.58602531 |
| 85 | PRKCZ | 0.58314150 |
| 86 | MAPK13 | 0.57348342 |
| 87 | ERBB4 | 0.56636841 |
| 88 | ILK | 0.56416629 |
| 89 | FES | 0.54652922 |
| 90 | STK11 | 0.52793621 |
| 91 | NTRK3 | 0.51641812 |
| 92 | PRKCH | 0.51417214 |
| 93 | LMTK2 | 0.49275458 |
| 94 | CAMK4 | 0.48339440 |
| 95 | PRKD3 | 0.47852011 |
| 96 | * FYN | 0.47272747 |
| 97 | KSR1 | 0.47242388 |
| 98 | BRAF | 0.47036759 |
| 99 | CSNK1D | 0.45837027 |
| 100 | BMPR1B | 0.45056155 |
| 101 | PRKG1 | 0.44635764 |
| 102 | RAF1 | 0.42344678 |
| 103 | RET | 0.41802584 |
| 104 | CSNK1A1 | 0.41163144 |
| 105 | MAP3K1 | 0.41075784 |
| 106 | PDK1 | 0.39422056 |
| 107 | IRAK1 | 0.39027402 |
| 108 | PRKG2 | 0.38790204 |
| 109 | PAK1 | 0.38169440 |
| 110 | MAP3K2 | 0.35572618 |
| 111 | PRKCA | 0.35177125 |
| 112 | TESK1 | 0.34993404 |
| 113 | MINK1 | 0.34759678 |
| 114 | TRPM7 | 0.32970847 |
| 115 | ERBB2 | 0.32882381 |
| 116 | PRKACB | 0.32850340 |
| 117 | ROCK1 | 0.31925984 |
| 118 | SRC | 0.31144356 |
| 119 | PDK2 | 0.30767258 |
| 120 | DMPK | 0.30593072 |
| 121 | RPS6KA5 | 0.30550293 |
| 122 | GSK3A | 0.30483704 |
| 123 | MAPK10 | 0.29879262 |
| 124 | PDGFRB | 0.29467295 |
| 125 | MAP2K4 | 0.29396215 |
| 126 | BMX | 0.28840941 |
| 127 | DAPK3 | 0.27020765 |
| 128 | JAK2 | 0.26869895 |
| 129 | PRKCB | 0.26300855 |
| 130 | CAMK1G | 0.25662860 |
| 131 | PINK1 | 0.25445233 |
| 132 | PRKACA | 0.25184387 |
| 133 | DDR2 | 0.24084493 |
| 134 | MAPK7 | 0.23619745 |
| 135 | DYRK1A | 0.23487654 |
| 136 | GRK7 | 0.23322011 |
| 137 | PRKCG | 0.23313083 |
| 138 | MAP2K2 | 0.22622948 |
| 139 | PTK2B | 0.22304984 |
| 140 | INSR | 0.22159264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.21903031 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.45123968 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.21427528 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.18986392 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.95701661 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.74265473 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.57595189 |
| 8 | Insulin secretion_Homo sapiens_hsa04911 | 2.43673115 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.32607754 |
| 10 | Axon guidance_Homo sapiens_hsa04360 | 2.12348734 |
| 11 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.92108817 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.86272389 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.76178105 |
| 14 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.74983724 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74404202 |
| 16 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.67779396 |
| 17 | GABAergic synapse_Homo sapiens_hsa04727 | 1.63649870 |
| 18 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.60182553 |
| 19 | Protein export_Homo sapiens_hsa03060 | 1.54746102 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.43929776 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.40303600 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.39469234 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.38824100 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.37282268 |
| 25 | Morphine addiction_Homo sapiens_hsa05032 | 1.33890337 |
| 26 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.33137097 |
| 27 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.29580390 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.27224155 |
| 29 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.23853065 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.23129173 |
| 31 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.22511315 |
| 32 | Parkinsons disease_Homo sapiens_hsa05012 | 1.20204698 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.18425004 |
| 34 | Long-term depression_Homo sapiens_hsa04730 | 1.16992397 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.15755104 |
| 36 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.14231817 |
| 37 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.13795933 |
| 38 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.13134050 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.13006647 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.11497491 |
| 41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.09579933 |
| 42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.06124800 |
| 43 | Nicotine addiction_Homo sapiens_hsa05033 | 1.05377242 |
| 44 | Glioma_Homo sapiens_hsa05214 | 1.03942940 |
| 45 | Circadian entrainment_Homo sapiens_hsa04713 | 1.02862772 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99408249 |
| 47 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97981248 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97895841 |
| 49 | Cocaine addiction_Homo sapiens_hsa05030 | 0.96100909 |
| 50 | Tight junction_Homo sapiens_hsa04530 | 0.94873684 |
| 51 | Endocytosis_Homo sapiens_hsa04144 | 0.93604410 |
| 52 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.92313282 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 0.92241578 |
| 54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.91567883 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90850018 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90165610 |
| 57 | Salivary secretion_Homo sapiens_hsa04970 | 0.88990047 |
| 58 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.86704399 |
| 59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84677427 |
| 60 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.84051938 |
| 61 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.82346010 |
| 62 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.82117371 |
| 63 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.79894790 |
| 64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.79398903 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77723553 |
| 66 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77416795 |
| 67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.77090863 |
| 68 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76991815 |
| 69 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.76730176 |
| 70 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.76480648 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.74949483 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74780867 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74198874 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72442331 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71997277 |
| 76 | Phototransduction_Homo sapiens_hsa04744 | 0.70145912 |
| 77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.70034044 |
| 78 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.68003515 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65278194 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62756018 |
| 81 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.62003463 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61350883 |
| 83 | Olfactory transduction_Homo sapiens_hsa04740 | 0.60228246 |
| 84 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.59877295 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59810237 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57354556 |
| 87 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.57227824 |
| 88 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.57188756 |
| 89 | Gap junction_Homo sapiens_hsa04540 | 0.56947014 |
| 90 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56654004 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55461408 |
| 92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54670435 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54444760 |
| 94 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.51526866 |
| 95 | Huntingtons disease_Homo sapiens_hsa05016 | 0.50973285 |
| 96 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.50550960 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.50340539 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.50016048 |
| 99 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49536013 |
| 100 | Renin secretion_Homo sapiens_hsa04924 | 0.49240209 |
| 101 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49097295 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48602363 |
| 103 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48237293 |
| 104 | Taste transduction_Homo sapiens_hsa04742 | 0.48136033 |
| 105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48111725 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | 0.47795934 |
| 107 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.47360084 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47326432 |
| 109 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46531779 |
| 110 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45774277 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45035172 |
| 112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43823605 |
| 113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43073722 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42715194 |
| 115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42631298 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.42323573 |
| 117 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42309521 |
| 118 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.41795173 |
| 119 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.41284117 |
| 120 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.38879308 |
| 121 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.36995974 |
| 122 | Malaria_Homo sapiens_hsa05144 | 0.35953629 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35519324 |
| 124 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35329355 |
| 125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35158367 |
| 126 | Alcoholism_Homo sapiens_hsa05034 | 0.33129130 |
| 127 | Peroxisome_Homo sapiens_hsa04146 | 0.32889098 |
| 128 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.32205500 |
| 129 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.31422261 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.30795484 |
| 131 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.30479601 |
| 132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30054722 |
| 133 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26486014 |
| 134 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.25333324 |
| 135 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24201647 |
| 136 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.23123655 |

